NO305990B1 - Nye prednisolonderivater - Google Patents

Nye prednisolonderivater

Info

Publication number
NO305990B1
NO305990B1 NO19953861A NO953861A NO305990B1 NO 305990 B1 NO305990 B1 NO 305990B1 NO 19953861 A NO19953861 A NO 19953861A NO 953861 A NO953861 A NO 953861A NO 305990 B1 NO305990 B1 NO 305990B1
Authority
NO
Norway
Prior art keywords
pct
new
prednisolone derivatives
sec
date
Prior art date
Application number
NO19953861A
Other languages
English (en)
Norwegian (no)
Other versions
NO953861L (no
NO953861D0 (no
Inventor
Hermann Amschler
Dieter Flockerzi
Richard Riedel
Stefan Postius
Michael Stoeck
Rolf Beume
Karl Zech
Beate Gutterer
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of NO953861L publication Critical patent/NO953861L/no
Publication of NO953861D0 publication Critical patent/NO953861D0/no
Publication of NO305990B1 publication Critical patent/NO305990B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO19953861A 1993-04-02 1995-09-29 Nye prednisolonderivater NO305990B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH102393 1993-04-02
PCT/EP1994/001015 WO1994022899A1 (fr) 1993-04-02 1994-03-31 Nouveaux derives de prednisolone

Publications (3)

Publication Number Publication Date
NO953861L NO953861L (no) 1995-09-29
NO953861D0 NO953861D0 (no) 1995-09-29
NO305990B1 true NO305990B1 (no) 1999-08-30

Family

ID=4200650

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19953861A NO305990B1 (no) 1993-04-02 1995-09-29 Nye prednisolonderivater

Country Status (21)

Country Link
US (1) US5733901A (fr)
EP (1) EP0701565B1 (fr)
JP (1) JP3333210B2 (fr)
KR (1) KR100330941B1 (fr)
CN (1) CN1062869C (fr)
AT (1) ATE172739T1 (fr)
AU (1) AU683463B2 (fr)
BG (1) BG62491B1 (fr)
CZ (1) CZ287877B6 (fr)
DE (1) DE59407183D1 (fr)
DK (1) DK0701565T3 (fr)
ES (1) ES2124884T3 (fr)
FI (1) FI113543B (fr)
HU (1) HU220868B1 (fr)
NO (1) NO305990B1 (fr)
NZ (1) NZ265054A (fr)
PL (1) PL179489B1 (fr)
RU (1) RU2132854C1 (fr)
SK (1) SK281226B6 (fr)
UA (1) UA45311C2 (fr)
WO (1) WO1994022899A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
NZ525707A (en) * 2000-11-10 2004-11-26 Altana Pharma Ag Process for the production of 16,17-[(cyclohexylmethylene) bis(oxy)]-11,21-dihydroxy-pregna-1,4-diene-3,20-dione or its 21-isobutyrate by transketalisation
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
KR101067795B1 (ko) * 2002-08-30 2011-09-27 니코메드 게엠베하 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도
PT1572217E (pt) * 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
US8435497B2 (en) * 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
US20060211668A1 (en) * 2003-09-15 2006-09-21 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
CA2579007A1 (fr) * 2004-09-10 2006-03-16 Altana Pharma Ag Combinaison de ciclesonide et d'inhibiteur de syk et procedes d'utilisation
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
CA2612364A1 (fr) * 2005-06-14 2006-12-28 Corus Pharma, Inc. Phenylphosphates substitues utilises en tant que promedicaments mutuels constitues de steroides et de .beta.-agonistes pour le traitement d'inflammation pulmonaire et de bronchoconstriction
WO2007054974A2 (fr) * 2005-09-28 2007-05-18 Arch Pharmalab Limited Procede de chimie verte pour la preparation d’esters de pregnadiene
WO2008015696A2 (fr) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Procédé pour préparer le ciclésonide
EP2392584A1 (fr) * 2006-09-19 2011-12-07 Cipla Limited Forme C cristalline du solvate de méthanol ciclésonide
PT2262823E (pt) * 2008-03-13 2013-03-05 Farmabios Spa Processo para a preparação de derivados de pregnano
ITMI20080645A1 (it) * 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
CA2754589C (fr) * 2009-03-09 2013-07-16 Mikasa Seiyaku Co., Ltd. Compose steroide
WO2011135585A2 (fr) 2010-04-28 2011-11-03 Cadila Healthcare Limited Solution pharmaceutique aqueuse de ciclésonide
US9109005B2 (en) * 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
CN103421075B (zh) * 2012-05-16 2017-07-28 上海特化医药科技有限公司 孕烷衍生物16,17‑缩醛(酮)的制备方法
AU2017274442B2 (en) 2016-06-02 2021-08-19 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
EP3884962A1 (fr) 2017-12-01 2021-09-29 AbbVie Inc. Agoniste du récepteur aux glucocorticoïdes et immunoconjugués correspondants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.

Also Published As

Publication number Publication date
PL179489B1 (pl) 2000-09-29
FI954579A (fi) 1995-09-27
EP0701565B1 (fr) 1998-10-28
FI113543B (fi) 2004-05-14
BG100032A (bg) 1996-05-31
CN1062869C (zh) 2001-03-07
HU220868B1 (en) 2002-06-29
JP3333210B2 (ja) 2002-10-15
FI954579A0 (fi) 1995-09-27
DK0701565T3 (da) 1999-07-12
KR100330941B1 (ko) 2002-10-12
CZ287877B6 (cs) 2001-03-14
NO953861L (no) 1995-09-29
CZ252995A3 (en) 1996-01-17
NO953861D0 (no) 1995-09-29
WO1994022899A1 (fr) 1994-10-13
JPH08508278A (ja) 1996-09-03
UA45311C2 (uk) 2002-04-15
NZ265054A (en) 1997-08-22
SK281226B6 (sk) 2001-01-18
AU683463B2 (en) 1997-11-13
ES2124884T3 (es) 1999-02-16
CN1120339A (zh) 1996-04-10
EP0701565A1 (fr) 1996-03-20
RU2132854C1 (ru) 1999-07-10
HU9502819D0 (en) 1995-11-28
DE59407183D1 (de) 1998-12-03
AU6538194A (en) 1994-10-24
HUT72594A (en) 1996-05-28
SK122395A3 (en) 1996-01-10
US5733901A (en) 1998-03-31
PL311474A1 (en) 1996-02-19
BG62491B1 (bg) 1999-12-30
ATE172739T1 (de) 1998-11-15

Similar Documents

Publication Publication Date Title
DK0701565T3 (da) Nye prednisolonderivater
TW285667B (fr)
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
AU7345391A (en) Derivative of beta-phenylisoserine, preparation and utilisation thereof
TW261614B (fr)
TW251283B (fr)
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
AU6675794A (en) Benzo(F)quinoxalindione derivatives, their preparation and their use in drugs
CA2159627A1 (fr) Nouveaux derives de la prednisolone

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

MK1K Patent expired